Lesions located inside and beyond the bowel demonstrate the extent of disease in a fused PET/CT image acquired at the National Cancer Center Hospital East in Kashiwa City, Japan, using an eight-slice Discovery LS from GE Healthcare. The volumetric scan fuses data acquired during tumor uptake of FDG and contrast-enhanced CT. Such data sets typically host the reconstruction of transaxial, coronal, and sagittal slices, but, in this case, the data were fashioned into a volumetric image that served as a guide for surgical resection of the tumor. Experimental software integrated PET data regarding the tumor and CT data representing vasculature, selected soft tissue, and bone. GE has developed a commercial version, the Advantage Windows Volume Viewer Plus. (Provided by GE Healthcare)
Lesions located inside and beyond the bowel demonstrate the extent of disease in a fused PET/CT image acquired at the National Cancer Center Hospital East in Kashiwa City, Japan, using an eight-slice Discovery LS from GE Healthcare. The volumetric scan fuses data acquired during tumor uptake of FDG and contrast-enhanced CT. Such data sets typically host the reconstruction of transaxial, coronal, and sagittal slices, but, in this case, the data were fashioned into a volumetric image that served as a guide for surgical resection of the tumor. Experimental software integrated PET data regarding the tumor and CT data representing vasculature, selected soft tissue, and bone. GE has developed a commercial version, the Advantage Windows Volume Viewer Plus. (Provided by GE Healthcare)
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.